Sandra Bhatt

Sandra Bhatt leads research on colorectal cancer prevention with a focus on chemoprevention strategies for high-risk individuals including Lynch syndrome and FAP patients. Her research has investigated aspirin, NSAIDs, and metabolic agents as potential chemopreventive agents for colorectal cancer in hereditary and sporadic settings. She has characterized lifestyle and dietary risk factors for colorectal cancer in genetically predisposed populations. Her translational prevention trials are advancing evidence-based chemoprevention recommendations for high-risk colorectal cancer patients.